Sign Up Today and Learn More About EndoGastric Solutions Stock
Invest in or calculate the value of your shares in EndoGastric Solutions or other pre-IPO companies through EquityZen's platform.
EndoGastric Solutions Stock (ENDS)
EGS manufactures EsophyX technology is used to reconstruct the gastroesophageal valve in the TIF 2.0 procedure.
About EndoGastric Solutions Stock
Founded
2003
Headquarters
San Mateo, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
EndoGastric Solutions, Inc. (www.endogastricsolutions.com), is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of GERD. EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) 2.0 procedure—a minimally invasive solution that addresses a significant unmet clinical need. EndoGastric Solutions, Inc. was founded in 2003 and is headquartered in Redmond, Washington.
EndoGastric Solutions Management
Leadership team at EndoGastric Solutions
President & CEO
Skip Baldino
Corporate Compliance Officer
Steve Hoffman
Join now and verify your accreditation status to gain access to:
- EndoGastric Solutions current valuation
- EndoGastric Solutions stock price
- Available deals in EndoGastric Solutions and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in EndoGastric Solutions stock?
Accredited investors can buy pre-IPO stock in companies like EndoGastric Solutions through EquityZen funds. These investments are made available by existing EndoGastric Solutions shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell EndoGastric Solutions stock?
Shareholders can sell their EndoGastric Solutions stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
